
High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer
Keywords: سرطان نازوفارنکس; Nasopharyngeal cancer; Chemoradiotherapy; ERCC1; Cisplatin; Prognostic factor